JPS5632967B2 - - Google Patents

Info

Publication number
JPS5632967B2
JPS5632967B2 JP11095974A JP11095974A JPS5632967B2 JP S5632967 B2 JPS5632967 B2 JP S5632967B2 JP 11095974 A JP11095974 A JP 11095974A JP 11095974 A JP11095974 A JP 11095974A JP S5632967 B2 JPS5632967 B2 JP S5632967B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP11095974A
Other versions
JPS5058216A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5058216A publication Critical patent/JPS5058216A/ja
Publication of JPS5632967B2 publication Critical patent/JPS5632967B2/ja
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP11095974A 1973-09-26 1974-09-26 Expired JPS5632967B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2348334A DE2348334C2 (de) 1973-09-26 1973-09-26 Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs

Publications (2)

Publication Number Publication Date
JPS5058216A JPS5058216A (ja) 1975-05-21
JPS5632967B2 true JPS5632967B2 (ja) 1981-07-31

Family

ID=5893666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11095974A Expired JPS5632967B2 (ja) 1973-09-26 1974-09-26

Country Status (12)

Country Link
US (1) US3979520A (ja)
JP (1) JPS5632967B2 (ja)
AT (1) AT330954B (ja)
BE (1) BE820254A (ja)
CA (1) CA1029661A (ja)
DE (1) DE2348334C2 (ja)
FI (1) FI58068C (ja)
FR (1) FR2244455B1 (ja)
GB (1) GB1420907A (ja)
NL (1) NL174222C (ja)
SE (1) SE402210B (ja)
ZA (1) ZA745967B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3326167A1 (de) * 1983-07-20 1985-02-21 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Feste arzneiformen, die als wirkstoff n-4-(2-(5-chlor-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'-cyclohexylharnstoff enthalten und verfahren zu ihrer herstellung
CA1282405C (en) * 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
DE3833439A1 (de) * 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
MX9706449A (es) * 1995-02-28 1997-11-29 Hoechst Marion Roussel Inc Composicion farmaceutica para compuestos de piperidinalcanol.
WO1999009957A1 (en) * 1997-08-26 1999-03-04 Hoechst Marion Roussel, Inc. Pharmaceutical composition for combination of piperidinoalkanol-decongestant
DK0974356T3 (da) * 1998-07-15 2003-10-27 Merck Sante Sas Tabletter omfattende en kombination af metformin og glibenclamid
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) * 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
WO2006109175A2 (en) * 2005-04-11 2006-10-19 Aurobindo Pharma Limited Solid dosage form of an antidiabetic drug
CN104098489A (zh) * 2014-07-10 2014-10-15 沈阳药科大学 一种微粉化格列本脲及其组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB694280A (en) * 1950-09-19 1953-07-15 Merck & Co Inc A stable, non-caking suspension of cortisone acetate in an isotonic aqueous vehicle and the process of preparing said composition
US3008873A (en) * 1957-02-07 1961-11-14 Merck & Co Inc Controlled particle size of 4, 4-dinitrocarbanilide
GB1030395A (en) * 1962-12-26 1966-05-25 Upjohn Co Hypoglycemic sulphonyl urea medicaments
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3454635A (en) * 1965-07-27 1969-07-08 Hoechst Ag Benzenesulfonyl-ureas and process for their manufacture
DE2017495A1 (en) * 1970-04-11 1971-11-04 Merck Patent Gmbh, 6100 Darmstadt Sulphonamides embedded in galactomannans
JPS4932056B1 (ja) * 1970-12-22 1974-08-27

Also Published As

Publication number Publication date
FI58068B (fi) 1980-08-29
NL7412393A (nl) 1975-04-01
ZA745967B (en) 1975-11-26
DE2348334A1 (de) 1975-03-27
US3979520A (en) 1976-09-07
AU7365374A (en) 1976-04-01
CA1029661A (en) 1978-04-18
GB1420907A (en) 1976-01-14
DE2348334C2 (de) 1982-11-11
FI58068C (fi) 1980-12-10
FR2244455A1 (ja) 1975-04-18
SE402210B (sv) 1978-06-26
JPS5058216A (ja) 1975-05-21
NL174222B (nl) 1983-12-16
FR2244455B1 (ja) 1978-07-21
SE7412044L (ja) 1975-03-27
NL174222C (nl) 1984-05-16
FI275574A (ja) 1975-03-27
BE820254A (fr) 1975-03-24
ATA762374A (de) 1975-10-15
AT330954B (de) 1976-07-26

Similar Documents

Publication Publication Date Title
AR201758A1 (ja)
AU476761B2 (ja)
AR201235Q (ja)
AR201231Q (ja)
AU474593B2 (ja)
AU474838B2 (ja)
AU465453B2 (ja)
AU471343B2 (ja)
AU465434B2 (ja)
FR2244455B1 (ja)
AU476714B2 (ja)
AR201229Q (ja)
AU476696B2 (ja)
AU466283B2 (ja)
AU472848B2 (ja)
AR199451A1 (ja)
AU477823B2 (ja)
AU477824B2 (ja)
AR200885A1 (ja)
AU471461B2 (ja)
AR201432A1 (ja)
AR193950A1 (ja)
AU476873B1 (ja)
AR200256A1 (ja)
AR195311A1 (ja)